Member Info for moonparty

And the good thing about cohort 4 is that it doesn't delay timelines, might make the outcome better, and gains us massive publicity and visibility with the CVLP.

If they are clutching at straws why have they signalled the registration trial decision for before any readout of chort 4?

If they already know iscib1+ is not as good as scib1, they would postone the decision to at least the first readout of cohort 4 to see if the intradermal made enough of a difference.

Your logic makes no sense.

Seems to me that it is exactly as it sounds - iscib1+ is better (certainly that was the impression reading between the lines on Thursday), but intradermal might make it better still.

Violin, the spread is large because there is an absence of sellers - MMs can easily sell stock at the moment, but are struggling to buy any to cover themselves, hence a wide a spread to mitigate the risk that they sell some short and are unable to buy them back from the market at a profit.

There is clearly a very large demand for shares (as I posted below you can sell 750K an auto which I have never seen before on this stock).

But whoever is accumulating is being canny - they want to pay as little as possible, hence testing the water at current levels, hoping for some traders who got in at sub-10p to let some go. Problem is, I think the traders have already left the room, so I would expect the MM will have to slowly raise their bid to attract the volume of sells required.

Crusty, do you mean 10.8p? - that's what I'm being offer for 125K, and 10.55p for 750k

Sorry, 3/4 million, 750000

They are hoping for sells to come in form the traders following the investor meet yesterday, but so far nobody is playing game. Expect the bid to rise if this stalemate continues.

You can currently sell up to 750,000 (quarter of a million) shares on auto within the advertised spread.

I have never seen such a high volume on the bid side.

Missed this when watching live, but on rewatch, in the first few minute:ls:

"Strategic partnering ... Is part of scancells future... we are now evaluating options to build greater shareholder value in the Glymabs pipeline"

ST, nobody consistently monitors and posts negatively on boards without motivation, so is it:

- financial, wanting cheaper shares or paid to post by somebody else who wants cheaper shares?

- phycological, you just get a kick from winding people up and laughing at others?

Either way, not to be trusted.

Won't give a detailed account as no time to and I'm sure it will become accessible to all.

Very very positive, great perfomrance from L'huillier, the confidence shone through and the face said it all - knowing smiles at several key questions.

I am very happy with that and looking forward to the next updates.

Here and 'over there' to keep a lid on any excitement after the fantastic news last week.

Personally I am quite excited as to what will be said tomorrow.

As another poster said (apols can't remember who), a lot of threads are coming together.

Krafty, you can sign up for free and register for the Scancell meeting :

https://www.investormeetcompany.com/upcoming-meetings

BuddhaBob - easy, £8 😀

Seriously though, no idea. If it all goes well probably several pounds? There is a high element of risk in predicting this type of share 3 years into the future, much easier with blue chips / funds.

Just a thought, and not sure this is usual or viable in biotech, but it can be a good way to release investor value.

Maybe someone is interested in Glymab, but Scancell don't want to completely let it go, they could spin it off as a separate company, split shares, say one quarter to Scancell, one quarter to existing investors and sell half the shares to the interested party to raise enough funds to take it forward at speed. They would then have effective control but Scancell would still have an interest, and a potential way to raise funds for the other pipelines, by selling their shares.

Investors would be happy, and L’Huillier comes off as a genius for non-dilutive funding and giving value to investors.

Can we get back to waiting and petty grown-up squabbles 😁

Not sure if these large trades can extend over several days, but you make a good point CP.

Probably best to look at the price action, and that shows us their is clear buying pressure.

Crusty that 2.5M would be a trade worked throughout the day - almost impossible to say if it was a buy or sell, but I suspect a buy, hence the price action.

What knocked the official closing price (but not the spread) was the 40000 UT (auction) trade - so all thing being equal, we will open at 11.375p tomorrow. Though honestly I expect this to go higher tomorrow - there is clearly a lot of demand based on todays news, and there will be lots of new investors, professional and amateur alike, doing their research off the back of todays news, and potentially taking a position over the next few days.

Rose into the close, finished on the high of the day, very bullish.

Is it safe to say the calculus overhang is an ex-overhang?

Just wondering if this news means the CVLP will now be covering costs that were previously going to be covered by Scancell? Apologies if this has already been discussed, there are a lot of posts today!

A minor thing compared to the fast-tracking, but if it also means the cash runway is extended beyond H2 2026 that would be nice.

Just checked in and I see the pump/dump posters have started crawling out from under their stones.

Never mind, the breadth of the coverage should mean the sp will show strong gains for a good few days as new investors research and take positions. Then hopefully start trending upwards.

Well done to all long termers for keeping the faith!